Literature DB >> 29982938

Knowledge of Hepatitis C Risk Factors is Lower in High Incidence Regions.

Terry Knick1, Jacqueline E Sherbuk2, Rebecca Dillingham3.   

Abstract

Despite ambitious goals to eliminate hepatitis C virus (HCV) in the United States by 2030, the majority of those infected are not aware of their diagnosis, and only a small minority have been cured. A lack of knowledge regarding risk factors and treatment may contribute to low cure rates. We aimed to evaluate HCV knowledge and the association of risk factor knowledge with HCV incidence. In fall 2017, a survey regarding HCV knowledge was disseminated through social media, web link, and in person throughout the state of Virginia. The survey was completed by 613 individuals. Residents of high-incidence counties identified fewer risk factors (5.6 vs 6.1 of 9, p = 0.04), a difference that remained significant when controlling for education and age (p = 0.03). Fewer participants in the high-incidence group recognized snorting drugs to be a risk factor (25% vs 36%, p = 0.01). Only 38% of all respondents correctly identified HCV to be curable. Knowledge of HCV risk factors is lower in high incidence regions. These results identify a critical knowledge gap in the general population at a time of ongoing HCV transmission. Public health interventions must target these gaps in high-incidence regions as part of comprehensive disease prevention programs.

Entities:  

Keywords:  Hepatitis C; Intranasal transmission; Knowledge; Public health; Risk factors; Substance abuse

Mesh:

Year:  2019        PMID: 29982938      PMCID: PMC7034878          DOI: 10.1007/s10900-018-0545-6

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  14 in total

1.  Hepatitis C transmission, prevention, and treatment knowledge among patients with HIV.

Authors:  Rae Jean Proeschold-Bell; Rachel Blouin; Susan Reif; Arit Amana; Benjamin J Rowland; Frank Lombard; Beth Stringfield; Andrew J Muir
Journal:  South Med J       Date:  2010-07       Impact factor: 0.954

2.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

3.  Limited uptake of hepatitis C treatment among injection drug users.

Authors:  Shruti H Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas
Journal:  J Community Health       Date:  2008-06

4.  Intranasal transmission of hepatitis C virus: virological and clinical evidence.

Authors:  Sagiv Aaron; James M McMahon; Danielle Milano; Leilani Torres; Michael Clatts; Stephanie Tortu; Donna Mildvan; Malgorzata Simm
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

5.  Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.

Authors:  Jane Vermunt; Margaret Fraser; Peter Herbison; Anna Wiles; Martin Schlup; Michael Schultz
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

6.  Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance.

Authors:  Marija Zeremski; Rositsa B Dimova; Roberto Zavala; Steven Kritz; Melissa Lin; Bryce D Smith; Jon E Zibbell; Andrew H Talal
Journal:  J Addict Med       Date:  2014 Jul-Aug       Impact factor: 3.702

7.  Formal patient education improves patient knowledge of hepatitis C in vulnerable populations.

Authors:  Miranda Surjadi; Cara Torruellas; Claudia Ayala; Hal F Yee; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2010-10-24       Impact factor: 3.199

8.  Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment.

Authors:  Zahra Alam-Mehrjerdi; Afsaneh Moradi; Fenglian Xu; Mehran Zarghami; Javad Salehi-Fadardi; Kate Dolan
Journal:  Addict Health       Date:  2016-04

9.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

10.  Community-based HCV screening: knowledge and attitudes in a high risk urban population.

Authors:  Brianna L Norton; Corrine I Voils; Sarah H Timberlake; Emily J Hecker; Neela D Goswami; Kim M Huffman; Anneka Landgraf; Susanna Naggie; Jason E Stout
Journal:  BMC Infect Dis       Date:  2014-02-10       Impact factor: 3.090

View more
  1 in total

1.  Increasing Viral Hepatitis Knowledge Among Urban Ethnic Minority Youth: Findings from a Community Based Prevention Intervention.

Authors:  Ijeoma Opara; David T Lardier; Andriana Herrera; Pauline Garcia-Reid; Robert J Reid
Journal:  J Community Health       Date:  2020-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.